Vertanical unpacks Phase 3 success for cannabis-based painkillernews2025-10-01T11:01:14+00:00October 1st, 2025|Endpoints News|
After building Ochre Bio, Jack O’Meara’s newest biotech raises $21M for neuro siRNAsnews2025-10-01T11:00:29+00:00October 1st, 2025|Endpoints News|
What we do and don’t know after the White House’s deal with Pfizernews2025-09-30T21:12:54+00:00September 30th, 2025|Endpoints News|
FDA approves Novartis’ BTK inhibitor for chronic hivesnews2025-09-30T20:57:00+00:00September 30th, 2025|Endpoints News|
‘Likely’ government shutdown threatens to stress an already depleted FDAnews2025-09-30T18:28:30+00:00September 30th, 2025|Endpoints News|
Under new CEO, Novo ends heart failure partnership with Japanese biotechnews2025-09-30T15:33:01+00:00September 30th, 2025|Endpoints News|
Merck makes the case for PAH drug Winrevair in patients with earlier diseasenews2025-09-30T15:04:43+00:00September 30th, 2025|Endpoints News|
Barinthus’ reverse merger with private biotech; Sutro to lay off 33% of employeesnews2025-09-30T14:36:27+00:00September 30th, 2025|Endpoints News|
MFN updates: Trump drug price announcement on most favored nationnews2025-09-30T14:23:45+00:00September 30th, 2025|Endpoints News|
